BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25441435)

  • 1. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.
    Zelnick LR; Katz R; Young BA; Correa A; Kestenbaum BR; de Boer IH; Bansal N
    Am J Kidney Dis; 2017 Aug; 70(2):199-206. PubMed ID: 28143672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating Time to ESRD in Children With CKD.
    Furth SL; Pierce C; Hui WF; White CA; Wong CS; Schaefer F; Wühl E; Abraham AG; Warady BA; ;
    Am J Kidney Dis; 2018 Jun; 71(6):783-792. PubMed ID: 29653769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD.
    Chu CD; McCulloch CE; Hsu RK; Powe NR; Bieber B; Robinson BM; Raina R; Pecoits-Filho R; Tuot DS
    Am J Kidney Dis; 2023 Oct; 82(4):386-394.e1. PubMed ID: 37301501
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study.
    Yu Z; Rebholz CM; Wong E; Chen Y; Matsushita K; Coresh J; Grams ME
    Am J Kidney Dis; 2019 Sep; 74(3):310-319. PubMed ID: 31031087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M
    Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Astor BC; Coresh J
    Am J Kidney Dis; 2010 Jan; 55(1):31-41. PubMed ID: 19932544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Midlife Obesity and Kidney Function Trajectories: The Atherosclerosis Risk in Communities (ARIC) Study.
    Yu Z; Grams ME; Ndumele CE; Wagenknecht L; Boerwinkle E; North KE; Rebholz CM; Giovannucci EL; Coresh J
    Am J Kidney Dis; 2021 Mar; 77(3):376-385. PubMed ID: 32979415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).
    Chen TK; Estrella MM; Astor BC; Greene T; Wang X; Grams ME; Appel LJ
    Nephrol Dial Transplant; 2015 Aug; 30(8):1329-35. PubMed ID: 25817226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
    Hallan SI; Rifkin DE; Potok OA; Katz R; Langlo KA; Bansal N; Ix JH
    Kidney Int; 2019 Sep; 96(3):728-737. PubMed ID: 31301887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital.
    Hickson LJ; Chaudhary S; Williams AW; Dillon JJ; Norby SM; Gregoire JR; Albright RC; McCarthy JT; Thorsteinsdottir B; Rule AD
    Am J Kidney Dis; 2015 Apr; 65(4):592-602. PubMed ID: 25500361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality.
    Ku E; Kopple JD; Johansen KL; McCulloch CE; Go AS; Xie D; Lin F; Hamm LL; He J; Kusek JW; Navaneethan SD; Ricardo AC; Rincon-Choles H; Smogorzewski M; Hsu CY;
    Am J Kidney Dis; 2018 May; 71(5):657-665. PubMed ID: 29217305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.
    Broder A; Mowrey WB; Khan HN; Jovanovic B; Londono-Jimenez A; Izmirly P; Putterman C
    Semin Arthritis Rheum; 2018 Feb; 47(4):545-551. PubMed ID: 28803673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
    Lewis J; Greene T; Appel L; Contreras G; Douglas J; Lash J; Toto R; Van Lente F; Wang X; Wright JT;
    J Am Soc Nephrol; 2004 Dec; 15(12):3175-83. PubMed ID: 15579521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
    Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
    Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.